Modulating tumor-stromal crosstalk via a redox-responsive nanomedicine for combination tumor therapy.
Zhang Y, Zhou J, Chen X, Li Z, Gu L, Pan D, Zheng X, Zhang Q, Chen R, Zhang H, Gong Q, Gu Z, Luo K.
Zhang Y, et al. Among authors: zhang q, zhang h.
J Control Release. 2023 Apr;356:525-541. doi: 10.1016/j.jconrel.2023.03.015. Epub 2023 Mar 15.
J Control Release. 2023.
PMID: 36918084